CDE Detailed Report
Disease: system
Subdomain Name: Laboratory Tests and Biospecimens/Biomarkers
CRF: files
Displaying 101 - 110 of 110
Subdomain Name: Laboratory Tests and Biospecimens/Biomarkers
CRF: files
Displaying 101 - 110 of 110
CDE ID | CDE Name | Variable Name | Definition | Short Description | Question Text | Permissible Values | Description | Data Type | Disease Specific Instructions | Disease Specific Reference | Population | Classification (e.g., Core) | Version Number | Version Date | CRF Name (CRF Module / Guidance) | Subdomain Name | Domain Name | Size | Input Restrictions | Min Value | Max Value | Measurement Type | External Id Loinc | External Id Snomed | External Id caDSR | External Id CDISC |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C18875 | Gene targeted variant mutational analysis other text | GeneTarVarMutAnlysisOTH | The free-text field related to 'Gene targeted variant or mutational analysis type', specifying other text. Type of targeted variant or mutational analysis performed for the gene | The free-text field related to 'Gene targeted variant or mutational analysis type', specifying other text. Type of targeted variant or mutational analysis performed for the gene | Other, specify | Alphanumeric | Adult | Supplemental | 3.20 | 2024-02-29 15:54:57.0 | Parkinson's Disease Genetics | Laboratory Tests and Biospecimens/Biomarkers | Assessments and Examinations | 4000 |
Free-Form Entry |
|||||||||||
C59093 | Database of Genotypes and Phenotypes phenotype study accession number text | DbGapPhsAcesionsnNumTxt | The free-text field to specify the study phenotype study (phs) accession number for the database of Genotypes and Phenotypes (dbGaP) study | The free-text field to specify the study phenotype study (phs) accession number for the database of Genotypes and Phenotypes (dbGaP) study | If YES, please provide the phs accession number and/or title of the study | Alphanumeric | Question and permissible values from dbGaP/database of Genotypes and Phenotypes/ National Center for Biotechnology Information, National Library of Medicine (NCBI/NLM)/https://www.ncbi.nlm.nih.gov/gap used and modified with permission. | Adult | Supplemental | 1.00 | 2022-07-28 09:30:27.0 | Parkinson's Disease Genetics | Laboratory Tests and Biospecimens/Biomarkers | Assessments and Examinations | 255 |
Free-Form Entry |
||||||||||
C12797 | Gene targeted variant mutational analysis type | GeneTarVarMutAnlysisTyp | Type of targeted variant or mutational analysis performed for the gene | Type of targeted variant or mutational analysis performed for the gene | If YES, type of analysis | Hot-spot;Other, specify;Known familial variant | Hot-spot;Other, specify;Known familial variant | Alphanumeric | Adult | Supplemental | 3.20 | 2024-02-29 15:54:56.0 | Parkinson's Disease Genetics | Laboratory Tests and Biospecimens/Biomarkers | Assessments and Examinations |
Single Pre-Defined Value Selected |
||||||||||
C12818 | Gene second allele identical indicator | GeneSecondAlleleIdenticalInd | Indicator of whether allele #2 is identical to allele #1 | Indicator of whether allele #2 is identical to allele #1 | Is allele #2 identical to allele #1 | Yes;No | Yes;No | Alphanumeric |
Homozygous only If NO, repeat filling out allele specific information for Allele #2" |
Adult | Supplemental | 3.10 | 2024-02-29 15:55:05.0 | Parkinson's Disease Genetics | Laboratory Tests and Biospecimens/Biomarkers | Assessments and Examinations |
Single Pre-Defined Value Selected |
|||||||||
C19607 | Genetic test mitochondrial DNA variant mutation quantitative analysis heteroplasmy level type | GenetcTestMDNAMQntAnHLTyp | Type of heteroplasmy level in quantitative analysis for mitochondrial DNA variant or mutation | Type of heteroplasmy level in quantitative analysis for mitochondrial DNA variant or mutation | Quantitative analyses (Heteroplasmy assessment) Heteroplasmy level | Blood;Muscle;Urinary sediment;Buccal cells;Other | Blood;Muscle;Urinary sediment;Buccal cells;Other | Alphanumeric | Adult | Supplemental | 2.00 | 2024-02-29 15:55:07.0 | Parkinson's Disease Genetics | Laboratory Tests and Biospecimens/Biomarkers | Assessments and Examinations |
Single Pre-Defined Value Selected |
||||||||||
C59163 | Genotype platform version text | GenotypePlatformVersionTxt | The free-text field to specify the genotype platform version | The free-text field to specify the genotype platform version | Name and version | Alphanumeric | Question and permissible values from dbGaP/database of Genotypes and Phenotypes/ National Center for Biotechnology Information, National Library of Medicine (NCBI/NLM)/https://www.ncbi.nlm.nih.gov/gap used and modified with permission. | Adult | Supplemental | 1.00 | 2022-07-28 11:32:32.0 | Parkinson's Disease Genetics | Laboratory Tests and Biospecimens/Biomarkers | Assessments and Examinations | 255 |
Free-Form Entry |
||||||||||
C16198 | Biological sample in repository consent form signed indicator | BioSampInReposConsentFmSignInd | Indicates whether the participant provided signed informed consent for the biological sample collection and storage in a repository | Indicates whether the participant provided signed informed consent for the biological sample collection and storage in a repository | Did the participant sign a consent form at the time the sample was taken? | Yes;No;Unknown | Yes;No;Unknown | Alphanumeric | Adult | Supplemental-Highly Recommended | 3.20 | 2024-02-29 15:54:09.0 | Parkinson's Disease Genetics | Laboratory Tests and Biospecimens/Biomarkers | Assessments and Examinations |
Single Pre-Defined Value Selected |
||||||||||
C59076 | Response anti parkinsonism therapy status | RespnsAntiParknsmTherapyStat | Status of the participant's/subject's response to anti-parkinsonism therapy | Status of the participant's/subject's response to anti-parkinsonism therapy | Response to anti-parkinsonism therapy | Tested and unresponsive;Inadequate dose;Not tried/not given;Tried and responsive | Tested and unresponsive;Inadequate dose;Not tried/not given;Tried and responsive | Alphanumeric | Question and permissible values from Coriell Institute for Medical Research used and modified with permission.<br />https://www.coriell.org/1/About-Us/Legal-Notice | Adult | Supplemental-Highly Recommended | 1.00 | 2022-07-27 21:31:16.0 | Parkinson's Disease Genetics | Laboratory Tests and Biospecimens/Biomarkers | Assessments and Examinations |
Single Pre-Defined Value Selected |
|||||||||
C12785 | Gene variant mutation detected result type | GeneVarMutDetectedResltTyp | Type of gene variant or mutation detected | Type of gene variant or mutation detected | Variant(s) detected | Compound Heterozygous;No pathogenic variant detected;Heterozygous;Digenic (variants in more than one gene);Homozygous;Hemizygous | Compound Heterozygous;No pathogenic variant detected;Heterozygous;Digenic (variants in more than one gene);Homozygous;Hemizygous | Alphanumeric | Adult | Supplemental | 3.10 | 2024-02-29 15:54:39.0 | Parkinson's Disease Genetics | Laboratory Tests and Biospecimens/Biomarkers | Assessments and Examinations |
Multiple Pre-Defined Values Selected |
||||||||||
C59174 | Genetic test result participant inform indicator | GeneTestRsltPatInfrmInd | Indicator of whether the participant was informed of the genetic test results | Indicator of whether the participant was informed of the genetic test results | Was the patient informed of the test results? | No;Yes | No;Yes | Alphanumeric |
If YES, indicate source of the information |
Adult | Supplemental-Highly Recommended | 1.10 | 2024-02-29 15:54:03.0 | Parkinson's Disease Genetics | Laboratory Tests and Biospecimens/Biomarkers | Assessments and Examinations |
Single Pre-Defined Value Selected |
- « first
- ‹ previous
- 1
- 2
- 3